ArticleBlood2009

T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model.

Antonio Di Stasi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.